SUMMARY
INTRODUCTION
A fine balance between immune activation and suppression is vital for an organism to control pathogen infection and tumor formation while preventing autoimmune diseases. Regulatory T cells (Tregs) , a subset of Foxp3-expressing CD4 + T cells, play a crucial role in immune suppression. In vivo, Tregs are either developed in the thymus (tTregs) with expression of Nrp1 and Helios or differentiated from naive CD4 + T cells in the peripheral organs (pTregs). In vitro, Tregs can also be differentiated from naive CD4 + T cells by stimulation of cytokines such as transforming growth factor β (TGF-β) and retinoic acid (RA) (in vitro differentiated regulatory T cells [iTregs] ). Under certain conditions (e.g., inflammation and/or homeostatic proliferation), Tregs can lose Foxp3 expression and become exTregs (Rubtsov et al., 2010) . Maintenance of Treg stability is critical for their suppressive function. Tregs expressing the transcriptional factor Blimp-1 have an activated phenotype and are considered effector Tregs (eTregs) (Cretney et al., 2013) . eTregs also express ST2 and KLRG1 and are abundantly present in peripheral tissues, such as the gut, skin, and fat (Cipolletta et al., 2012; Delacher et al., 2017; Schiering et al., 2014; Vasanthakumar et al., 2015) . In contrast, Blimp-1-negative Tregs have been termed central Tregs (cTregs) (Liston and Gray, 2014) . Current knowledge regarding eTreg generation and function remains limited.
Emerging evidence suggests that precise metabolic regulation is important for Treg homeostasis and function. mTORC1 signaling positively regulates Treg function in mice by promoting cholesterol and lipid metabolism and upregulation of the suppressive molecules cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and inducible T cell costimulatory (ICOS) (Zeng et al.,2013) . Deletion of the metabolic sensor Stk11 in Tregs disrupts mitochondrial fitness and metabolism . The Toll-like receptors (TLRs) TLR1 and TLR2 promote Treg proliferation by increasing glycolysis but also impair Tregsuppressive capacity in mice (Gerriets et al., 2016) , whereas TLR8 signaling selectively inhibits glucose uptake and glycolysis in human Tregs and inhibits their suppressive function (Li et al., 2018a) . Foxp3 can suppress glycolysis through inhibition of phosphatidylinositol 3-kinase (PI3K)-Akt-mTORC1 signaling (Gerriets et al., 2016) and induces oxidative phosphorylation (OXPHOS) through suppression of Myc expression (Angelin et al., 2017; Gerriets et al., 2016) . High OXPHOS activity facilitates Treg function in low-glucose and high-lactate environments in peripheral organs, such as the large intestine (Angelin et al., 2017) .
Human and mouse mitochondrial genomes contain 13 protein-coding genes that are essential for the mitochondrial respiratory chain (Kazachkova et al., 2013; Schon et al., 2012) . Tfam is a nuclear gene encoding transcriptional factors crucial for mitochondrial respiration by regulating mitochondrial DNA replication, transcription, and packaging (Picca and Lezza, 2015) . Tfam germline knockout in mice leads to embryonic lethality (Larsson et al., 1998) , indicating a vital role of Tfam-mediated mitochondrial respiration in embryo development. Conditional deletion of Tfam in hematopoietic stem cells (HSCs) in mice is also lethal because of a severe decrease in embryo-derived red blood cells (Ansó et al., 2017) . Celltype-specific deletion of Tfam in T cells by the CD4-Cre transgene causes severe mitochondrial respiration defects, lysosomal storage disorders, and enhanced proinflammatory interferon γ (IFN-γ) production by CD4 + T cells (Baixauli et al., 2015) but has no obvious effect on Treg maintenance in the thymus and spleen. A recent report showed that Tfam deletion in Tregs decreases gut Tregs, but the precise mechanism is unclear (Chapman et al., 2018 ).
Here we generated mice with specific deletion of Tfam in Tregs to study the role of Tfammediated mitochondrial respiration in Treg development and function. Our data revealed a selective requirement for Tfam to regulate tissue-resident Treg maintenance (homing and stability) and function in the gut, skin, and fat in the steady state and in the tumor microenvironment. Mechanistically, Tfam promotes gene activation in Tregs through DNA de-methylation and is essential for Treg proliferation and Foxp3 expression, especially in low-glucose environments. Our work suggests that the metabolic environment can affect Treg homeostasis and function via Tfam-dependent mitochondrial respiration.
RESULTS

Treg-Specific Deletion of Tfam Results in Severe Inflammation in Mice
To define the cell-intrinsic role of Tfam in Tregs, we crossed mice carrying loxP Consistent with previous reports that Tfam controls mitochondrial DNA replication and transcription, we detected a significant decrease of mitochondrial DNA content ( Figure S1B ) and mitochondrial gene-encoded mRNAs ( Figure S1C ) in Tfam-deficient Tregs compared  with control Tregs, suggesting defective mitochondrial respiration in Tfam-deficient Tregs. Compared with littermate controls, Tfam fl/fl Foxp3 Yfp-Cre mice manifested reduced body size, severe loss of hair and body adipose tissue, and skin ulceration ( Figure 1A ). Tfam fl/fl Foxp3 Yfp-Cre mice were able to survive beyond 6 weeks of age (data not shown) but gradually lost body weight after 4 weeks of age ( Figure 1B ). The mutant mice had lymphadenopathy of peripheral lymph nodes, whereas the spleen and mesenteric lymph nodes (mLNs) appeared similar compared with control mice ( Figure S1D ). Histological analysis showed severe leukocyte infiltration in Tfam fl/fl Foxp3 Yfp-Cre mice in multiple organs, such as the skin, lung, and liver ( Figure 1C ). The morphology and length of the small and large intestine were similar, except that mild leukocyte infiltration was apparent in the cecum of Tfam fl/fl Foxp3 Yfp-Cre mice ( Figure 1C ; Figure S1E ). Compared with those in littermate control mice, both CD4 + T and CD8 + T cells in Tfam fl/fl Foxp3 Yfp-Cre mice showed a significant increase in the memory and effector population (CD44 hi CD62L lo ) in various lymphoid and non-lymphoid tissues ( Figure 1D ; Figure S1F ). Cytokine production by CD4 + T cells, such as interleukin-17A (IL-17A), IFN-γ, tumor necrosis factor (TNF), IL-4, IL-5, and IL-13, was significantly increased in multiple organs of Tfam fl/fl Foxp3 Yfp-Cre mice (Figures 1E and 1F; Figures S1G and S1H) . Overall, the development of severe systemic inflammation in multiple organs and tissues in Tfam fl/fl Foxp3 Yfp-Cre mice revealed that Tfam in Tregs has a crucial role in maintenance of immune homeostasis.
Cell-Intrinsic Control of Tissue-Resident Tregs by Tfam
Compared with littermate controls, the percentage of Tregs among CD4 + T cells in Tfam fl/fl Foxp3 Yfp-Cre mice was greatly reduced in non-lymphoid organs such as the gut, fat, and skin but not significantly changed in the spleen or even slightly increased in other lymphoid organs, including the thymus, inguinal lymph nodes (iLNs), and mLNs (Figures 2A and 2B) , suggesting a special requirement for Tfam to regulate the Treg compartment in certain peripheral organs. Of note, Tregs also showed a significant decrease in the large intestine but not in the spleen of Tfam fl/fl Foxp3 Yfp-Cre mice compared with control mice at 1 week and 3 weeks of age, when the Tfam fl/fl Foxp3 Yfp-Cre mice did not display obvious inflammatory disease ( Figures S2A-S2D ). Fluorescence-activated cell sorting (FACS) analysis of Annexin V and cleaved caspase-3 and real-time RT-PCR analysis of expression of the apoptotic and anti-apoptotic genes Bax and Bcl-xl showed no significant difference between control and Tfam-deficient Tregs ( Figures S2E-S2G ), consistent with a previous report showing that Tfam deficiency has no significant effect on CD4 + T cell survival (Baixauli et al., 2015) . In addition, similar Ki67 staining was observed in control and Tfamdeficient intestinal Tregs ( Figure S2H ). Together, these data suggested that Tfam deficiency in Tregs did not affect Treg survival or proliferation in vivo. Figure 2C ; Figure S3A ), indicating cellintrinsic regulation of Tregs by Tfam in certain peripheral organs. Given the low-glucose environment in the gut, fat, and skin (Angelin et al., 2017; Schaupp et al., 1999; Sternberg et al., 1995) , we reasoned that Tfam might affect Tregs under low-glucose conditions. To this end, we cultured Tregs under various in vitro conditions. Although Tfam-sufficient Tregs proliferated equally well in glucose-free medium or with 2-DG (a glycolysis inhibitor) treatment compared with glucose-sufficient medium, Tfam-deficient Tregs had greatly reduced proliferation ( Figure 2D ; Figure S3B ). Furthermore, Tfam-deficient Tregs lost more Foxp3 expression in glucose-free medium or with 2-DG treatment compared with control Tregs ( Figure 2E ; Figure S3C ). These data suggest that Tfam-deficient Tregs are more sensitive to glucose deprivation in vitro.
Tfam Deficiency Affects Treg-Suppressive Function
We next asked whether Tfam regulates Treg-suppressive function. Compared with littermate control Tregs, intestinal Tfam-deficient Tregs produced less of the immunoregulatory molecules IL-10 and amphiregulin (Areg) but similar amounts of IL-17A and IFN-γ ( Figures 3A-3D ). To further determine whether Tfam deficiency affected Treg function, we conducted in vitro and in vivo Treg suppression assays. Tfam-deficient Tregs had a similar ability to suppress CD4 + T cell or CD8 + T cell proliferation in vitro compared with control Tregs ( Figure S3D ). However, in vivo, Tfam-deficient Tregs had impaired suppressive activity in the CD45RB hi T cell transfer model of colitis ( Figures 3E-3G ). Specifically, increased accumulation of CD4 + T cells, neutrophil infiltration, and production of the proinflammatory cytokines IFN-γ and IL-17A by effector CD4 + T cells were observed in the large intestine of recipient mice that received co-transferred naive CD4 + T cells and Tfam-deficient Tregs compared with those that received co-transferred control Tregs ( Figure  3G ; Figure S3E ). A trend of reduction in transferred Tregs (CD45.2 + )that were deficient in Tfam was also observed in the recipient mice ( Figure S3E) Figure 4A ). We further compared the list of reported Foxp3 directly bound and regulated genes in spleen and lymph node Tregs (333 DEGs) (Samstein et al., 2012; Zheng et al., 2007) and the differentially expressed gene list identified in control and Tfam-deficient spleen and lymph node Tregs in our current study (246 DEGs). Only 8 genes overlapped (Abcbla, Cobll1, Icos, Nrp1, Prdm1, Rnf125, Snx9, and Tnfsf11) ( Figure S4A ). These data suggest that differential regulation of these genes observed in Tfam-deficient Tregs was less likely to be directly regulated by Foxp3 but, instead, due to defects of Tfam expression and mitochondrial respiration. Among the 246 DEGs, 238 genes (96.7%) were decreased, whereas only 8 genes (Afap1, Zfp661, Slc25a27, Cfap74, Als2cl, Fbxo17, Npb, and Marco) (3.3%) were increased in Tfam-deficient Tregs ( Figure 4A ), suggesting that Tfam predominantly functions as a transcription activator in Tregs. Consistent with the crucial role of Tfam in regulation of mitochondrial gene transcription (Picca and Lezza, 2015) , all mtDNA protein-coding genes (a total of 13) involved in the respiratory chain were significantly reduced in Tfam-deficient Tregs ( Figure  4B ). In addition, genes related to Treg function (e.g., Pdcd1, Icos, Tigit, Il10, Klrg1, and Il1rl1) were downregulated in Tfam-deficient Tregs ( Figure 4B ), consistent with impaired Treg-suppressive activity. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses of 246 differentially expressed genes revealed significant enrichment of the cytokine-cytokine receptor interaction and chemokine signaling pathways (Figures 4B and 4C; Figure S4B ) between control and Tfam-deficient Tregs.
A recent study showed that genetic ablation of the mitochondrial complex III components Rieske iron-sulfur protein (RISP, encoded by Uqcrfs1) and ubiquinone-binding protein (QPC, encoded by Uqcrq) in Tregs affects mitochondrial respiration, leading to defective Treg function (Weinberg et al., 2019) . Because Tfam is important for mitochondrial respiration (Baixauli et al., 2015) , we compared the DEGs between control and Tfamdeficient spleen and lymph node Tregs in our study (246 DEGs) with the DEGs between control and RISP-deficient spleen and lymph node Tregs (fold change ≥ 1.5, q ≤ 0.05, a total of 185 DEGs). Despite regulation of genes that encode for mitochondrial complex I, III, IV, and V by Tfam Figure 4B ), RNA-seq analysis showed different expression patterns regulated by Tfam and RISP ( Figure S4C ). Strikingly, a small cohort of 49 genes overlapped ( Figure S4C ; Table S1 ), among which four chemokine receptors or adhesion molecules (Ccr2, Ccr4, Itgae, and Gpr15) shared the differential expression pattern ( Figure S4D ), suggesting a critical role of mitochondrial respiration in regulating Treg homing.
Next, we used the assay for transposase-accessible chromatin sequencing (ATAC-seq) to determine whether Tfam deficiency affected general chromatin accessibility in Tregs. Among 91,731 identified DNA peaks, only 153 peaks associated with 135 genes showed a significant change between control and Tfam-deficient Tregs (Figures 4D and 4E; . Of note, 16 of the 135 genes showed differential expression, revealed by RNAseq analysis ( Figure 4E ; Figure S4E ). Among the 16 genes, Il10, Tigit, and Serpina3g, reported to be important for Treg function and/or regulated by Foxp3 (Dominguez-Villar and Hafler, 2018; Grinberg-Bleyer et al., 2010) , were decreased at the transcriptional level, accompanied by lower chromatin accessibility in Tfam-deficient Tregs compared with control Tregs ( Figure 4F ). Together, our results suggest that Tfam positively regulates the expression of a select group of genes in Tregs through a mechanism primarily independent of changing chromatin accessibility.
Tfam Is Critical for Maintenance of ST2 + KLRG1 + Tregs
Gene set enrichment analysis (GSEA) of RNA-seq data indicated enrichment of an eTreg gene signature in control Tregs compared with a cTreg gene signature in Tfam-deficient Tregs ( Figure 5A ), suggesting that Tfam deficiency specifically affected the eTreg compartment. However, CD44 and CD62L expression between control and Tfam-deficient Tregs was not significantly changed either at the mRNA level, as shown by our RNA-seq results (data not shown), or at the protein level ( Figures S5A and S5B ). Prdm1 (encoding Blimp1) and Batf, important for eTreg maintenance and function (Cretney et al., 2011; Vasanthakumar et al., 2015) , were significantly decreased in Tfam-deficient Tregs ( Figure  5B ). Klrg1 (encoding KLRG1) and Il1rl1 (encoding ST2), both highly expressed by eTregs, were also downregulated in Tfam-deficient Tregs (Figures 4B and 5B) . ST2 + KLRG1 + Tregs are abundantly present in peripheral tissues, such as the gut, skin, and fat, but less present in lymphoid organs (Cipolletta et al., 2012; Delacher et al., 2017; Schiering et al., 2014; Vasanthakumar et al., 2015) . Consistent with mRNA data, ST2 + KLRG1 + 
Tfam Deficiency Affects Treg Homing and Retention in Peripheral Non-lymphoid Tissues
GSEA of RNA-seq data revealed a significant difference in the chemokine-mediated signaling pathway between control and Tfam-deficient Tregs ( Figure 5F ). Specifically, chemokine receptors involved in lymphocytes homing to the skin (Ccr8 and Itage; Braun et al., 2015; Schaerli et al., 2004) , liver (Ccr4 and Cxcr3; Oo et al., 2010) , and small and large intestine (Ccr5, Ccr6, Ccr10, Gpr15, and Itgae; Fischer et al., 2016; Habtezion et al., 2016) were significantly reduced in Tfam-deficient Tregs (Figures 4B and 5G) . We also performed an in vivo homing assay for Tregs by transferring mixed Treg-containing splenic CD4 + T cells from CD45.1/CD45.2-Tfam +/+ Foxp3 Yfp-Cre and CD45.2/CD45.2-Tfam fl/fl Foxp3 Yfp-Cre mice to Ragl −/− recipients to check Treg homing 20 h after adoptive cell transfer ( Figure   5H ). We failed to recover any Tregs from the skin at the time point after cell transfer (data not shown). In contrast to lymphoid tissue, spleen, and lymph nodes, we found that Tfamdeficient Tregs were less homed to the liver and small and large intestine ( Figure 5I ; Figure  S5E ), indicating that Tfam deficiency in Tregs impaired Treg homing and/or retention in selective non-lymphoid organs at the periphery.
Tfam Deficiency in Tregs Switches Oxidative Phosphorylation toward Glycolysis
Because Tfam controls the expression of mitochondrial gene-encoded proteins essential for respiration, we first measured mitochondrial mass by Mitotracker DeepRed staining. Paradoxically, the results showed an increase in mitochondrial mass in Tfam-deficient Tregs compared with control Tregs ( Figures S6A and S6B) . Similarly, mitochondrial membrane potential (MMP) staining by tetramethylrhodamine ethyl ester (TMRE), a cell-permeant fluorescent dye for active mitochondria, showed that MMP was also increased in Tfamdeficient Tregs ( Figures S6A and S6B ). In addition, by MitoSox staining, mitochondrial reactive oxygen species (ROS) showed an increase in Tfam-deficient Tregs compared with control Tregs (Figures S6A and S6B) . Using a high-resolution confocal microscope, we found an increase in mitochondrial size in Tfam-deficient Tregs compared with control Tregs ( Figure S6C ), consistent with reported observations that mitochondrial size is compensatorily increased in Tfam-deficient cells compared with control cells (Baixauli et al., 2015; Larsson et al., 1998) .
To further monitor the metabolic changes in Tregs, we measured the oxygen consumption rate (OCR), an indicator of mitochondrial respiration activity, and the extracellular acidification rate (ECAR), an indicator of glycolytic activity (Divakaruni et al., 2014) . The data showed that basal, maximal, and coupled OCRs were significantly decreased in Tfamdeficient Tregs compared with control Tregs ( Figures S6D and S6E ). Tfam-deficient Tregs did not completely lose mitochondrial respiration activity (Figures S6D and S6E) , consistent with residual but significantly reduced mitochondrial gene transcription ( Figure S1C ). In contrast, both basal and maximal ECARs were significantly increased in Tfam-deficient Tregs ( Figures S6F and S6G ). Uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-de-oxyglucose (2-NBDG), a fluorescent glucose analog for monitoring glucose uptake in live cells, was increased in Tfam-deficient Tregs compared with control Tregs ( Figure S6H ). Together, these data suggest that Tfam-deficient Tregs switch oxidative phosphorylation toward glycolysis.
Tfam Is Critical for Foxp3 Stability in Tregs
Maintenance of Foxp3 expression is critical for Treg-suppressive function (Rubtsov et al., 2010; Sakaguchi et al., 2013) . In the CD45RB hi T cell transfer model of colitis ( Figure 3E 
Dysregulated Mitochondrial Metabolism Results in DNA Hypermethylation
Mitochondrial metabolism metabolites, such as acetyl-coenzyme A(CoA), α-ketoglutarate (α-KG), 2-hydroxyglutarate(2-HG), succinate, and fumarate, are not only intermediates generated during the tricarboxylic acid (TCA) cycle but are also important for modulating gene expression through epigenetic mechanisms (Carey et al., 2015; Mehta et al., 2017) .
5-Methylcytosine (5meC) is a methylated cytosine form of genome DNA involved in suppression of gene transcription (Breiling and Lyko, 2015; Shen et al., 2014) . We next checked whether Tfam deficiency in Tregs altered the DNA 5meC level. To this end, we purified Tregs from the spleen and pLNs of control and Tfam-deficient mice and subjected them to a DNA dot blot assay using a 5meC antibody. The results showed hyperme-thylation of genomic DNA in Tfam-deficient Tregs compared with control Tregs ( Figure 6H ), suggesting that Tfam regulates DNA methylation in Tregs.
Because DNA demethylation in the Treg-specific demethylation region (TSDR) of the Foxp3 locus is critical for Foxp3 stability (Li and Zheng, 2015) , we determined the effect of 
Tfam Deficiency Affects Treg Maintenance in the Tumor Microenvironment and Anti-tumor Immunity
Tumors have been reported to be a low-glucose and high-lactate environment and to provide a highly glucose-competitive niche for immune cells (Gullino et al., 1964; Ho et al., 2015) . Because Tfam-deficient Tregs were more dependent on glucose for proliferation and maintenance of Foxp3, we next asked whether Tfam deficiency in Tregs also impairs Treg maintenance in tumors. A recent report showed that B16 melanoma has a comparatively elevated glycolytic environment (Cascone et al., 2018) Impairment of Tregs and their suppressive function has been reported to promote tumor rejection (Klages et al., 2010; Kline et al., 2012; Pedros et al., 2017; Yu et al., 2018) . To determine the role of Tfam in Tregs in tumor immunity, we crossed Tfam fl/fl mice with Foxp3 eGFP-Cre-ERT2 mice (whose Cre nuclear localization and subsequent gene deletion were induced by tamoxifen) to specifically and inducibly delete Tfam in Tregs and subsequently challenged the mice with B16-OVA ( Figure 7D ). Our data showed that Tregs were significantly decreased in tumor tissues but not in the spleen upon tamoxifen treatment ( Figure S7A) . A marked reduction in the Treg to Foxp3 − CD4 + T cell ratio and Treg to CD8 + T cell ratio in tumors ( Figures S7B and S7C) , consistent with tumor growth retardation, was observed in Tfam fl/fl Foxp3 eGFP-Cre-ERT2 mice compared with Tfam fl/+ Foxp3 eGFP-Cre-ERT2 mice (Figures 7E and 7F ; Figure S7D ).
To further determine the role of Tfam in Treg-mediated tumor immunity, we co-transferred CD25-depleted total splenic cells (from CD45.1/CD45.1 C57BL/6 mice) with control or Tfam-deficient Tregs (CD45.2/CD45.2) to Rag1 −/− recipient mice that were injected with B16-OVA tumor cells ( Figure 7G ). Consistent with the literature (Pedros et al., 2017) , mice receiving co-transferred CD25-depleted splenic cells and control Tregs showed faster tumor growth than mice receiving CD25-depleted splenic cells only. Notably, we found that mice receiving co-transferred CD25-depleted splenic cells and Tfam-deficient Tregs controlled tumors more efficiently compared with those receiving co-transferred Tfam-sufficient Tregs (Figures 7H and 7I ; Figure S7E ). Fewer tumor-infiltrating CD45.1 − CD4 + T cells (i.e., donor Tregs) were recovered from tumors of mice receiving Tfam-deficient Tregs compared with mice receiving control Tregs ( Figures 7J and 7K) . Furthermore, Tfam-deficient Tregs severely lost Foxp3 expression compared with control Tregs ( Figures 7J and 7L) . Accordingly, more tumor-infiltrating CD8 + T cells were found in mice receiving Tfamdeficient Tregs compared with those receiving control Tregs ( Figure 7M ). Together, these data suggested that Tfam-deficient Tregs were less maintained in the tumor microenvironment, resulting in augmented anti-tumor immunity.
DISCUSSION
Despite the impairment of mitochondrial respiration in Tregs, Treg maintenance was not affected by Tfam ablation in the steady state in lymphoid organs but perturbed in certain nonlymphoid organs and tissues, such as the fat, gut, and skin. In tumors, Treg maintenance and Foxp3 stability were also markedly affected by Tfam deficiency. It is known that certain organs, such as the fat, skin, and gut, under physiological conditions, share with the tumor microenvironment a low-glucose tissue milieu. We hypothesized that Tfam in Tregs conveys a different sensitivity to environmental glucose changes so that lack of Tfam will affect Tregs in certain tissues. Consistent with this notion, Tfam deficiency impaired Treg proliferation and Foxp3 expression by inhibition of the glycolysis pathway in vitro. Of note, in vivo proliferation of Tfam-deficient Tregs appeared to be unchanged based on Ki67 staining (data not shown), at least in the gut, suggesting that yet to be defined factors and/or metabolic changes in vivo may compensate for the glucose reduction.
Several metabolites from the mitochondrial TCA cycle (e.g., acetate, α-KG, succinate, and fumarate) have been reported to regulate gene expression through epigenetic modifications, such as DNA methylation or demethylation and histone acetylation, methylation, or demethylation (Carey et al., 2015; Mehta et al., 2017) . Given that Illrll and Klrgl were among the most significantly decreased genes identified in RNA-seq data, we analyzed the Illrll and Klrgl loci that contain active H3K4me3 and H3K27ac modifications reported previously (Li et al., 2018b) . However, we did not find obvious decreases in H3K4me3 or H3K27ac levels at the Illrll and Klrgl loci in Tfam-deficient Tregs compared with control Tregs (data not shown), suggesting that the decrease in gene expression, at least for Illrll or Klrgl in Tregs, was not due to a defect in these histone modifications at the Illrll or Klrgl locus. Deletion of Uqcrfsl, a gene encoding the mitochondrial complex III subunit RISP, has been reported to increase the fumarate/α-KG and succinate/α-KG ratios (Ansó et al., 2017) , which inhibit DNA demethylation and increase the DNA methylation level in RISP-deficient cells (Ansó et al., 2017; Carey et al., 2015) . Consistently, we found more DNA methylation in Tfam-deficient Tregs compared with control Tregs. Specifically, we found that DNA was hypermethylated at the TSDR of the Foxp3 locus, which resulted in loss of Foxp3 stability specifically in peripheral tissues (e.g., the gut).
Targeting metabolism for cancer therapy has been investigated for several decades (Luengo et al., 2017) . Although cancer cells largely increase glucose consumption and lactate production (called the Warburg effect), mitochondrial respiration inhibitors can block cancer cell proliferation, suggesting that mitochondrial respiration is still required for cancer cell proliferation (Schieber and Chandel, 2013; Weinberg et al., 2010; Wheaton et al., 2014; Zhang et al., 2014) . Both metformin and AG311, inhibitors of mitochondrial complex I, have been reported to cooperate with other therapies to resolve cancer regression in some human and mouse tumors (Bastian et al., 2017; Jiralerspong et al., 2009; Wheaton et al., 2014) . The mechanism of these chemicals in cancer therapy is thought to work, at least partially, through inhibition of tumor cell growth (Wheaton et al., 2014) . However, the current work suggests that the effect of inhibition of mitochondrial respiration in tumorinfiltrating lymphocytes needs to be considered. We found that inhibition of mitochondrial respiration in Tregs compromised Treg maintenance in the tumor environment but not in lymphoid tissues, resulting in promoted tumor rejection. Of note, recent research showed that reprogramming metabolism by enforcing PCG-1α expression, which promotes mitochondria biogenesis, or inhibition of glycolysis in CD8 + T cells inhibits tumor growth, indicating that mitochondrial respiration promotes the anti-tumor activity of CD8 + T cells (Scharping et al., 2016; Sukumar et al., 2013) . It is intriguing that certain tumors, such as melanoma, have been reported to have higher glycolytic activity, contributing to immunoevasion (Cascone et al., 2018) . Thus, targeted metabolic regulation of Tregs by specific inhibition of mitochondrial respiration in tumor-infiltrating Tregs may break the tolerance and warrants future consideration for certain cancer therapies.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice-All mice used in this study were maintained in SPF or Germ-free facilities at the University of Florida. The mice were littermate controlled and were 6-8 weeks old for experiments unless otherwise noted. Tfam fl/fl mice were kindly provided by Navdeep Chandel (Northwestern University). Foxp3 Yfp-Cre , Foxp3 eGFP-Cre-ERT2 mice, CD45.1 homo , Rag1 −/− and ROSA26 Stop-YFP mice were purchased from Jackson Laboratory. Cd4-Cre mice were purchased from Taconic Farms and breed in University of Florida. Experiments were performed with both male and female littermate animals of each genotype unless otherwise indicated. All studies with mice were approved by the Animal Care and Use Committees of the University of Florida.
METHOD DETAILS
Lymphocytes isolation and flow cytometry-The isolation of lymphocytes from thymus, spleen, peripheral/mesenchymal lymph nodes and intestinal lamina propria were performed as previously described (Ye et al., 2017) . Lung lymphocyte isolation was conducted by digesting minced lung tissues with collagenase IV (Sigma) and DNase I (Sigma) at 37°C for 90 min. Fat lymphocyte isolation was conducted by digesting minced peritoneal adipose tissues with collagenase II (Sigma) with DNase I at 37°C for 90 min. Skin lymphocyte isolation was conducted by digesting minced ear skin tissues with collagenase IA (Sigma) with DNase I at 37°C for 60 min. After digestion, cells were further purified from the interphase of 37.5% and 75% Percoll gradient after 18 minutes spin at 2,500 rpm at room temperature. For flow cytometry analysis, the live and dead cells were stained by Live and Dead violet viability kit (Invitrogen) or Zombie Aqua fixable viability kit (BioLegend). CD16/32 antibody (Thermo Fisher) was used to block the nonspecific binding followed by surface molecule staining at 4°C for 30 min. Cells were fixed and permeabilized with Foxp3 staining buffer Kit (eBioscience) for transcription factor staining. For cytokine staining, cells were stimulated with 50 ng/ml PMA and 500 ng/ml ionomycin for 4 hours and Brefeldin A (2 mg/ml) was added 2 hours before cells were harvested. Sample acquisition was performed on BD FACSCantoII or LSRFortessa flow cytometer and analyzed with FlowJo software (version 10.2). For some experiments, spleen or LN lymphocytes were enriched with CD4 + T cell isolation kit (Stemcell). BD FACSAriaII or Sony sorter SH800 were used for cell sorting.
Adoptive T cell transfers and T cell-mediated transfer model of colitis-Cells
with indicated number were transferred to gender-and age-matched recipient mice through intravenous injection unless otherwise noted. Mice were sacrificed for analysis at indicated time after transfer. CD45RB hi T cell transfer model of colitis was conducted as previously described (Ye et al., 2017) . Sorted naive 4 × 10 5 CD4 + CD25 − CD45RB high cells from the pooled spleen and lymph nodes of CD45.1 + congenic mice were intravenously injected into was s.c. injected. Cell co-transfer model of tumor was conducted as described (Pedros et al., 2017) . Basically, 15 × 10 6 CD25-depleted total splenic lymphocytes from CD45.1 mouse and 1 × 10 6 Tregs sorted from CD45.2 control or Tfam fl/fl Foxp3 Yfp-Cre mice were mixed and co-transferred to 8-week-old Rag1 −/− mice. B16-F10-OVA (5 × 10 5 ) cells were s.c. injected on the same day. Tumor growth was monitored with digital caliper.
Cell culture-Unless otherwise noted, Tregs were cultured in RPMI-1640 medium (plus β-mercaptoethanol) supplemented with 10% fetal bovine serum, 1% L-glutamine, 1% penicillin-streptomycin, 50 ng/ml IL-2 and anti-CD3/CD28 coated Dynabeads (Thermo Fisher) at 1:1 ratio (cells: beads). For glucose challenge experiments, glucose-free RPMI-1640 medium (Thermo Fisher, 1187020) were used. 2-DG was purchased from Sigma (D8375). For in vitro iTreg differentiation, 24-well plates were pre-coated with 40 μg/ml anti-hamster antibody (MP Biomedical). CD4 + CD25 − CD44 − CD62L + naive T cells were sorted and cultured for 3 days in IMDM (Sigma-Aldrich) supplemented with 0.25 μg/ml anti-CD3 (145-2C11), 1 μg/ml anti-CD28 (37.51), 2 μg/ml anti-IL-4 (11B11), 2 αg/ml anti-IFN-γ (XMG1.2) and 5 ng/ml TGF-β. For in vitro Treg suppression assay, splenocytes from CD45.1 + mice were labeled with Cell Trace Violet (Thermo Fisher) and cultured with or without various ratio of sorted splenic Tregs from control or Tfam fl/fl Foxp3 Yfp-Cre mice. Cells were cultured for 3d with soluble 1 μg/ml anti-CD3/CD28.
The division of CD45.1 + CD4 + T cells were assessed by the dilution of Cell Trace Violet.
Quantitative PCR-Total RNA was isolated with Trizol reagent (Invitrogen). cDNA was synthesized by GoScript Reverse Transcription kit (Promega). Real-time PCR was performed using SYBR Green (Biorad) and different primer sets (Table S2 ). Reactions were run using the CFX connect Real-Time PCR Detection System (Biorad). Each specific gene expression was normalized to β-actin expression. For mitochondrial DNA quantification, total DNA was isolated with QIAGEN DNeasy Blood &Tissue Kit (69504). Mitochondrial DNA abundancy (ND-1) was normalized to β-globin. Primer sequences for PCR were listed in Table S2 . OCR and ECAR measurements-OCR and ECAR in Tregs were measured in an XF96 extracellular flux analyzer (Seahorse Bioscience) as previous described (Anso et al., 2013 (Anso et al., ,2017 . Tregs were purified from pooled spleens and pLNs from 3 to 5 control or Tfam fl/fl Foxp3 Yfp-Cre mice for each sample. Cells were cultured in Seahorse medium during measurement. Cells were recovered in 37°C in RPMI-1640 medium-complete for 1h after sorting. Basal OCR was calculated by subtracting the OCR values after treatment with antimycin A and rotenone (Sigma) from the OCR values before oligomycin (Sigma) treatment. Maximal OCR was calculated by subtracting the OCR values after treatment with antimycin A and rotenone from the OCR values after CCCP (Sigma) treatment. Coupled respiration was determined by the subtraction of oligomycin A values from basal respiration values. Glycolytic flux was measured by the sensitivity of the extracellular acidification rate after 2-DG treatment.
RNA-Seq and ATAC-Seq analyses-Total RNA was extracted from about 1 × 10 6 sorted YFP + Tregs pooled from spleen and lymph node of 2 to 3 Tfam fl/+ Foxp3 Yfp-Cre/+ or Tfam fl/fl Foxp3 Yfp-Cre/+ female littermate mice with RNAeasy Mini Kit (QIAGEN), followed by DNase treatment (TURTBO DNA-freeTM Kit). mRNA was purified with NEBNext Poly(A) mRNA Magnetic Isolation kit (NEB) and RNA-seq libraries were generated using NEBNext Ultra II RNA library Prep Kit (NEB). Barcoded samples were sequenced on an Illumina HiSeq 2500 instrument to produce 50 bp single-end reads. The sequencing reads were mapped with HISAT2 to the Mus musculus genome (mm9 and mm10 assembly) and filtered for uniquely mapped reads. Quantitated mRNA expression levels, FPKM and count aligned reads, were calculated based on exon regions using the cufflinks and HTSeq respectively. Significantly changed genes (FPKM > 1 in either control or Tfam-deficient Treg group, fold change ≥ 1.5, q-value ≤ 0.05) were identified by DESeq2 analysis. Gene Set Enrichment Analysis were performed for GO and KEGG analysis. For ATAC-seq, 5×10 4 sorted splenic Tregs were lysed in lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). Pelleted nuclei were resuspended in transposition reaction mix with Tn5 transposase (Illumina) and incubated at 37°C for 30 min. The DNA was purified with MinElute PCR Purification Kit (QIAGEN) and was used as a template of PCR with 10 cycles of amplification. The library was cleaned up with 1.2x SPRIselect beads (Beckman Coulter) before sequencing with Illumia HiSeq 2500. ATAC-Seq reads were mapped to the mouse genome (mm9) with bowtie2. The mapped reads were filtered using samtools. Peak calling was performed with Homer and qualified with HTSeq and DESeq2. Genome-wide peaks were visualized with NGSplot.
DNA methylation dot blot analysis-DNA methylation dot blot analysis was conducted as previously described (Tran et al., 2017) . Genome DNA were isolated with DNeasy Blood &Tissue Kit (QIAGEN) followed by 99°C denaturing for 5 min. Genome DNA were loaded on nylon membrane (Amersham) and air dry for 5 min. 30 s UV light exposure was conducted. DNA-bonded membranes were blocked in 5% milk and stained with anti-5-methylcytosine antibody (Millipore, MABE146) at 4°C overnight. After 3 times wash with 0.1% PBT (0.1% tween 20 in 1x PBS), membranes were blotted with HRPconjugated goat anti-mouse second antibody for 30 min. The dot blot signal was visualized using BioRad ChemiDoc XRS+ system. DNA-loaded membranes were incubated with 0.02% methylene blue (Sigma, M9140) for 10 min for methylene blue staining.
TSDR methylation analysis-TSDR methylation analyses were performed as previously described (Ye et al., 2017) . Briefly, genomic DNA of indicated cells were isolated with DNeasy tissue kit (QIAGEN). Bisulfate conversion was performed with EZ DNA methylation Kit (Zymo Research). The primer sequences to amplify Foxp3 CpG island region are 5′-GGATTTGAATTGGATATGGTTTGTTTAG-3′ and 5′-CAACCTTAAACCCCTCTAACATCCAAA-3′. The PCR product was cloned using pGEM-T easy vector system (Promega) for sanger sequencing using T7 primer.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are represented as mean ± SD and have at least n = 3 per group (refer to figure legend to detailed information). Unless otherwise noted, statistical analysis was performed with the unpaired Student's t test. ANOVA tests were performed for statistical significance for Figure 2C . Statistical analysis were run using GraphPad Prism 7.04 software package. P values were indicated with asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001).
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